Skip to content
Back to Overview

Real-World Testing and Treatment Patterns in Lung Cancer to Inform Precision Oncology Care with Thermo Fisher

Join industry thought leaders from Integra Connect and Thermo Fisher on Thursday, November 16 at 12:00pm EST | 9:00am PST. November is Lung Cancer Awareness Month. While providers understand the growing role of genetics and genomics especially in cancer care, experts agree that genomic testing in discovery and treatment is still at the precipice and in need of greater adoption within the practice to accelerate initiatives and achieve better personalized medicine for patients. 

During this session, experts will discuss: 

  • What are the latest trends and updates in the genomic landscape?
  • What are the barriers that still exist in genomic testing for cancer care? What solutions could be implemented to address these barriers?
  • What recent ASCO research has been done in genomics with Thermo Fisher and RWE? Why was this research important?
  • What are some best practices to drive improvement in and around genomics at the point of care and beyond?

Jeffrey Scott, MD

Chief Medical Officer & President of Population Health at Integra Connect

Read more about Dr. Scott by visiting his bio. 

events-hero-min

Luca Quagliata, PhD

Vice President, Global Head of Medical Affairs at Thermo Fisher Scientific